Figure 1.
Overall survival curve for (a) ipilimumab (reproduced from Hodi et al.101), (b) sipuleucel-T (reproduced from Kantoff et al.115) and (c) PSA-TRICOM (reproduced from Kantoff et al.29)
Overall survival curve for (a) ipilimumab (reproduced from Hodi et al.101), (b) sipuleucel-T (reproduced from Kantoff et al.115) and (c) PSA-TRICOM (reproduced from Kantoff et al.29)